Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DR3:TL1A Inhibitor Screening Assay Kit

The DR3:TL1A Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of the interaction between DR3 (Death Receptor 3) and TL1A (TNF-like ligand 1A) . This kit comes in a convenient 96-well or 384-well format, with biotin-labeled TL1A (amino acids 72-end), purified DR3 (amino acids 25-199), streptavidin-labeled HRP, and assay buffer for 100 or 400 binding reactions.Figure 1:DR3:TL1A Inhibitor Screening Assay Kit workflow diagram.First, DR3 is coated on a 96-well or 384-well plate. Next, biotinylated TL1A is incubated with DR3. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence. The chemiluminescence signal is proportional to the binding of DR3:TL1ANeed us to run inhibitor screens or profile your compounds against DR3:TL1A? Check out ourImmunotherapy Biochemical Screening Services.

Product Specifications

Background

DR3 (death receptor 3), also known as tumor necrosis factor receptor superfamily member 25 or TNFRSF25, is a membrane receptor of the tumor necrosis factor receptor superfamily of proteins (TNFRSF), which associates with TL1A (TNF-like protein 1A) in T and NK cells. DR3 has been recognized as a significant anti-apoptotic and differentiation factor and it is a co-stimulatory receptor. TL1A, also called TNFSF15, is a member of the tumor necrosis factor family. It is expressed in different immune cells, such as monocyte, macrophage, dendritic cell, T cell and non-immune cells. TL1A competitively binds to DR3, having a higher affinity for DcR3 (decoy receptor 3), providing stimulatory signal for downstream signaling pathways. It then regulates proliferation, activation, apoptosis, and chemokine production in effector cells. The role of DR3 in T cell activation, and consequently in cytokine secretion and cell proliferation, makes it an attractive target in cancer therapy. Inhibition of DR3-TL1A interaction has substantial therapeutic potential in the treatment of solid tumors.

UniProt

O95150

Applications

Screen or titrate small molecule inhibitors or biologics for drug discovery and high-throughput screening (HTS) applications of the TL1A binding to DR3.

Format

96 ReactionsCatalog #NameAmountStorage101882TL1A, His-Tag, Avi-Tag, Biotin-Labeled*5 µg-80 °C102303DR3, His-Tag*25 µg-80 °C826205x PP-02 Buffer4 ml-20 °C82719Blocking Buffer 740 ml+4 °C79742Streptavidin-HRP10 µl+4 °C79670ELISA ECL Substrate A (translucent bottle) 6 mlRoom TempELISA ECL Substrate B (brown bottle) 6 mlRoom Temp7969996-well white microplate1Room Temp* The concentration of protein is lot-specific and will be indicated on the tube containing the protein.384 ReactionsCatalog #NameAmountStorage101882TL1A, His-Tag, Avi-Tag, Biotin-Labeled*2 x 5 µg-80 °C102303DR3, His-Tag*2 x 25 µg-80 °C826205x PP-02 Buffer4 ml-20 °C82719Blocking Buffer 72 x 40 ml+4 °C79742Streptavidin-HRP2 x 10 µl+4 °C79670ELISA ECL Substrate A (translucent bottle) 2 x 6 mlRoom TempELISA ECL Substrate B (brown bottle) 2 x 6 mlRoom Temp78188384-well white microplate1Room TempPlate sealing film1Room Temp* The concentration of protein is lot-specific and will be indicated on the tube containing the protein.

Storage Conditions

This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed

Notes

Troubleshooting GuideVisitbpsbioscience.com/assay-kits-faqfor detailed troubleshooting instructions. For all further questions, please email[email protected]

Contraindications

The final concentration of DMSO in the assay should not exceed 1%.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD5 (Cris-1), CF740 conjugate, 0.1mg/mL
BNC740176-100 1x 100 µL

CD5 (Cris-1), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL
BNC940304-500 1x 500 µL

CD106 / VCAM1 (B-K9), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
BNC400391-100 1x 100 µL

CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Histone H1 (AE-4), CF640R conjugate, 0.1mg/mL
BNC400096-500 1x 500 µL

Histone H1 (AE-4), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
BNC470977-500 1x 500 µL

TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11a (Cris-3), CF543 conjugate, 0.1mg/mL
BNC430151-500 1x 500 µL

CD11a (Cris-3), CF543 conjugate, 0.1mg/mL

Sign In for Pricing
View Details